​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Join Invest Vancouver, the Metro Vancouver region’s economic development leadership service, at life science leader Zymeworks’ Mount Pleasant HQ for conversation about the Metro Vancouver region’s life science industry. Featuring industry champions from across the region, our "​Life Sciences in Metro Vancouver: Shaping a Globally Prominent R&D” event will explore the strengths in life sciences in the Metro Vancouver region, the opportunities emerging in the region, and what actions are needed to support and advance the continued growth of the sector.

The Metro Vancouver region has a growing, export-oriented life sciences industry supported by a robust life sciences ecosystem and a pool of highly specialized talent. With a history of innovation that includes significant contributions to the development of the COVID-19 vaccine, the region is increasingly attracting global attention. Current economic uncertainty notwithstanding, the long-term outlook for the industry is bright. Invest Vancouver’s upcoming report “​Life Sciences in Metro Vancouver: Shaping a Globally Prominent R&D Hub” recommends three critical actions to level up this important industry.

Featured Speakers & Panelists​​

Neil Klompas
President and COO
Zymeworks Inc

Handol Kim
​CEO
Variational AI

Federica Di Palma
Chief Scientific Officer and Vice President, Research and Innovation
Genome BC

Jonathon Jafari
Lead Entrepreneur in Residence: Human Health Ventures Studio
entrepreneurship@UBC

Wendy Hurlburt
President and CEO
Life Sciences BC

Abi Coman-Walker
​Chief Operating Officer
Acuitas Therapeutics, Inc.

Murray McCutcheon
SVP Partnering
AbCellera

​

Linda Buchanan
Mayor, City of North Vancouver
Chair, Invest Vancouver Management Board

​​

Moderators

Lejla Uzicanin
Vice President, Data, Research and Policy
Invest Vancouver

​

Gregory Freeman
Senior Economist
Invest Vancouver​​​​​​